GANX - Gain Therapeutics, Inc. 0 WATCHERS

GANX touching $3.999 now, slow and steady and great support/resistance testing. Still a speculative play but think this goes large as more data comes out

GANX going brrrrr

Anyone else in GANX??

GT-02287 addresses multiple potential sources of Parkinson's ($GANX)

Careful about this one. Always check post history of commenters for GANX and you will find tons of bot accounts posting nothing about this stock.

Have a look at GANX. Not saying buy for the sake of buying, but look it up

Here is latest info including H.C. Wainwright update. Very interesting comments by him. Gain Therapeutics(GANX): Updated Analyst Reports with All Eyes on Biomarker readout in Q4 https://gaintherapeutics.wordpress.com/2025/11/16/gain-therapeuticsganx-updated-analyst-reports-with-all-eyes-on-biomarker-readout-in-q4/

GT-02287 addresses multiple potential sources of Parkinson's ($GANX) What’s the first domino in Parkinson’s disease? **Mainstream science points to the lysosome and α-synuclein aggregation—the idea that misfolded α-syn builds up because the lysosomal “trash system” breaks down. But what if that’s not where the problem starts?** The recent Neuroscience poster …

Just opened a position on GANX.

Gain Therapeutics($GANX) Initial Phase 1b results suggest disease slowing effect in Parkinson’s in just 90 days

Gain Therapeutics($GANX) Initial Phase 1b results suggest disease slowing effect in Parkinson’s in just 90 days

Don't miss out on GANX. Im in at 2.85

GANX. Cure/slow for Parkinson’s This is critical: GANX will not move gradually — it will move in violent jumps on news. Q1–Q2 2025 Phase 1b biomarker + functional interim data • Likely price reaction: +20% to +150% if strong • Or –20% to –50% if poor Q3–Q4 2025 Full Phase …

GANX is in the move. Going from 3.60 to 60$+ in next year. Parkinson’s cure.

Gain Therapeutics($GANX) Initial Phase 1b results suggest disease slowing effect in Parkinson’s in just 90 days

Gain Therapeutics($GANX) Initial Phase 1b results suggest disease slowing effect in Parkinson’s in just 90 days Gain Therapeutics will put out their 90 day phase 1b Parkinson’s trial data this month. This data will have 16 patients through the first 90 days of the trial. It will include biomarker data …

GANX December Updated Corporate Deck Getting one last GANX post in before the company rockets out of Pennystock land. I linked the new corporate slide deck. Note in slide 3 the bullet about GT-02287 that reads: “Initial results from Phase 1B suggest GT-02287 has a disease-slowing effect” That bullet statement …

GANX gonna graduate from Pennyland soon

GANX

Janx went down over 50% yesterday on news of some delays. Analysts say it was an overreaction, stock is barely outside of penny territory. Also GANX might pop, there s serious dd on it if you guys want to look

GANX break-out attempt

GANX only not breaking due to ATM-offering; that stock is coiling

GANX breakout brewing

GANX GANX GANX Expanded my position by 300%

GANX is rising on high volume, despite being 3 days after ATM-offering stock is up 8% trading on 80% volume compared to first day after ATM-offering was announced Catalyst (potentially first parkinsons decease modifying drug; phase 1b data announcement) in the coming weeks Current cap: 117M, this could explode I …

GANX might be leaving the station Data on potentially decease modifying parkinsons drug set to be announced in the coming weeks ATM-offering announced this weekend, stock dipped to 3; Has now recovered to VWAP of yesterday (>3.20), trading at >80% (!!) volume compared to first day after ATM-offering news Current …

GANX might be leaving the station Data on potentially decease modifying parkinsons drug set to be announced in the coming weeks ATM-offering announced this weekend, stock dipped to 3; Has now recovered to VWAP of yesterday (>3.20), trading at >80% (!!) volume compared to first day after ATM-offering news Current …

Dipped below 3 today, recovery to VWAP of yesterday, trading at >80% volume compared to first day after ATM-offering was announced; the GANX train might be leaving the station With data announcement imminent (1/2 weeks?)

Gain Therapeutics ($GANX) — quietly emerging as one of the most compelling Parkinson’s stories in biotech.

Gain Therapeutics ($GANX) — quietly emerging as one of the most compelling Parkinson’s stories in biotech. **The set-up that Gain Therapeutics has right now is extremely rare, IMO. Largely de-risked, and is only a week or two away from releasing what is likely some of the most compelling evidence of …

GANX (Big catalyst coming) and ETHZ ❤️

GANX

GANX

GANX Gain Therapeutics with December Parkinson’s Data

GANX

ETHZ and GANX 🙌🏻

GANX and ETHZ 🥳

GANX and ETHZ

GANX

GANX biomarker data to be announced this december, put a stop loss and hope for the best!

GANX

Gain Therapeutics $GANX Analyst Report highlights 3 unique Parkinson’s Models showing Mitochondrial Benefits

Gain Therapeutics $GANX Analyst Report highlights 3 unique Parkinson’s Models showing Mitochondrial Benefits A recent analyst report by H.C. Wainwright points out the significance of the most recent Neuroscience poster that Gain published recently. Many different studies have recently highlighted that mitochondrial health is tightly tied to the development of …

$GANX shows return of smell in Parkinson’s patients - Major December catalysts ahead

$GANX shows return of smell in Parkinson’s patients - Major December catalysts ahead For Gain Therapeutics 2025 has been a very busy year and as 2025 winds down the best is yet to come. In 2025 Gain has reported both Phase 1a and 1b data on their Parkinson’s disease modifying …

GANX! Look at their progress

GANX … interim data and company remarks point to improved motor function and return of sense of smell in Parkinson’s patients in 90 days. Full data readout in the next couple of weeks likely to establish GT-02287 as the most promising treatment for Parkinson’s disease, and the first disease modifying …

More $GANX https://preview.redd.it/hy00c1vpvk4g1.jpeg?width=1080&format=pjpg&auto=webp&s=6847d0ead7f6f1547d005d826d61ac64a51b2877

Holding GANX and waiting for biomarker data this december!

GANX

GANX Gain Therapeutics with December Parkinson’s Data

My Swan Song: How 20 Years of Grinding Led Me to $GANX

GANX, ARWR

Thanks. Great info. Truth is, it’s only a matter of days or weeks until the biomarker data is out. Potentially Life changing in many ways. Once people do their DD, I’m sure they’ll see there’s not many stocks that impress more than $GANX whether your outlook is short term, or …

I added the data chart. People will want to see it. Gain Therapeutics(GANX): Updated Analyst Reports with All Eyes on Biomarker readout in Q4 https://gaintherapeutics.wordpress.com/2025/11/16/gain-therapeuticsganx-updated-analyst-reports-with-all-eyes-on-biomarker-readout-in-q4/

GANX Gain Therapeutics with December Parkinson’s Data There have been multiple recent posts on Gain Therapeutics and that they will be releasing in December additional Phase 1b data. So far from the Phase 1b 90 day trial of 16 patients we have seen UPDRS scores on 9 of them. These …

GANX is NOT a meme or pump stock its a solid grower with high M&A potential my group is very bullish on it 10-12 mths for buyout is our target

GANX is a great move. Soon to release Parkinson’s disease cure info soon

GANX

maybe not a week but GANX

Lets see [GANX](http://aimytrade.io/ticker/GANX)

GANX

GANX is taking off.

GANX

GANX is the move!

Very well said and thank you for sharing a portion of your story. Like you, I have been studying the science and have decided to make my largest investment ever in GANX. The patient success stories almost feels like a horse is being led to water. I’m not going to …

Looking at your post history, you've been doing nothing for the past month except posting about this stock. At least a hundred comments and dozens of new threads started across multiple subreddits promoting it. Perhaps pumping GANX ***is*** your job?.

GANX

Gain Therapeutics(GANX): Updated Analyst Reports with All Eyes on Biomarker readout in Q4 gaintherapeutics.wordpress....

GANX

Gain Therapeutics($GANX) has returned Smell to Parkinson's patients in 2025 and has major catalysts before year end

So many exciting updates due with $GANX short term. Very exciting time to be a shareholder. Looking forward to getting specifics regarding patients smell returning etc. Risk/Reward here is one of the best I’ve ever seen.

GANX. about to explode. Parkinson’s disease cure. https://www.reddit.com/r/pennystocks/s/RbqMmqQTac

$GANX (Gain Therapeutics) Breaking Out, Optimism For Potential First Disease-Modifying Parkinson's Treatment **It’s still very early. Multiple catalysts in the next few weeks, and a ton of very strong pre-clinical and early clinical data. Parkinson's patients report regaining sense of smell, among other signals.** December could mark GANX’s transformation from …

I’m at a full position in $GANX, but can’t stop myself from adding more while we’re still massively undervalued. Obviously dependent on biomarker data, but the signs have never been clearer.

I do biotech M&A Dont flip PSTV & RVPH they are both great long term holds for buyout same with GANX

Looking forward to $GANX releasing their data in the next couple of weeks. Appreciate this post.

Most Asymmetric Opportunity in Biotech (and the whole market?) $GANX **It’s not often that an investment opportunity comes along with the asymmetric upside and limited downside that GANX has IMO, and in such a short timeline**. The problem is that most investors can’t take a casual glance at the company …

There is so much going for GANX right now. And while I love this as a long term hold, it is even more interesting because I don't think this will be a long-term hold. Full acquisition is very likely over the next few months, and that will be after what …

Why Gain Therapeutics (GANX) is ready to move

Why Gain Therapeutics (GANX) is ready to move Gain Therapeutics went public almost 4 years ago. They have been developing a Parkinson’s drug, GT-02287, that will hopefully delay the progression of Parkinson’s disease. Along the way they have done extensive preclinical work that not only looks like it could slow …

Really hoping GANX good news is coming out in December

Gain Therapeutics($GANX) has returned Smell to Parkinson's patients in 2025 and has major catalysts before year end

Gain Therapeutics($GANX) has returned Smell to Parkinson's patients in 2025 and has major catalysts before year end

Gain Therapeutics($GANX) has returned Smell to Parkinson's patients in 2025 and has major catalysts before year end For Gain Therapeutics 2025 has been a very busy year and as 2025 winds down the best is yet to come. In 2025 Gain has reported both Phase 1a and 1b data on …

$GANX showing real promise

(GANX) Gain Therapeutics presented new data today which supports the clinical improvements that it is showing in Parkinson's patients. Gain Therapeutics just [issued a new press release](https://gaintherapeutics.com/newsroom/press-releases/press-releases-2025/gain-therapeutics-presents-preclinical-gt-02287-data-at-neuroscience-2025/) and presented a [new scientific poster](https://gaintherapeutics.com/wp-content/uploads/2025/11/Poster-Neuroscience-2025.pdf) on GT-02287, and even though it looks technical, the takeaway is actually very simple: **The drug is …

Great info with data coming out at Neuroscience Conference today along with biomarker data to follow. Excting times coming up. Gain Therapeutics(GANX): Updated Analyst Reports with All Eyes on Biomarker readout in Q4 https://gaintherapeutics.wordpress.com/2025/11/16/gain-therapeuticsganx-updated-analyst-reports-with-all-eyes-on-biomarker-readout-in-q4/

Under-the-radar Parkinson’s drug on verge of establishing itself as the most promising treatment to stop disease progression. Likely 10X IMO (GANX) Gain Therapeutics ($GANX) looks to be sitting on one of the biggest under-the-radar biotech catalysts of the decade. Their drug, GT-02287, is targeting the root cause of Parkinson’s disease …

Been drooling over GANX…What’s everyone’s take?

Look, GANX is only going to talk about its drug at some show-and-tell thing. If it was closer to something, I'd be in. The other one, based in Mexico, yeah, that's in Mexico, and it has lost soooo much value- there HAS to be a reason for losing over $15 …

GANX